Aam’s annual savings report highlights that generic and biosimilar medicines created $467 billion in savings in 2024.. 2025 generic and biosimilar medicines savings report highlights value and vulnerability by john murphy iii, president & ceo,.
Generic & biosimilar medicines savings report generic and biosimilar medicines created $467 billion in savings in.. Generic & biosimilar medicines savings report was developed in partnership with the iqvia institute,.